COGT — Cogent Biosciences Inc
In 2026 Q2, 6 of the 140 tracked hedge funds reported a position in Cogent Biosciences Inc (COGT), worth $272.20M combined. Over the quarter 5 opened or added, 1 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Polar Capital | $125.11M | 0.35% | NEW |
| Emerald | $62.05M | 1.50% | +1% |
| Emerald Mutual | $39.91M | 1.40% | +0.2% |
| Renaissance | $38.55M | 0.05% | +41% |
| Persistent | $5.35M | 1.70% | +49.5% |
| Kohlberg | $1.23M | 0.02% | NO CHANGE |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.